SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in West Palm Beach, FL.

Stablecoin Development Corp.

SDEVs sharp, highly volatile run and reversal have fueled debate over a possible short squeeze, with traders also pointing to its SKY-token treasury exposure and the tokens rise. Bulls dispute dilution warnings and expect a squeeze, while bears call the move speculative and warn that potential share dilution could deepen the selloff.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs expanded Muskie data-campus power agreement, which doubles contracted capacity to 1 GW and brings the second phase forward, is driving attention as traders weigh the AI/HPC growth opportunity against buildout costs and execution risks. Many are frustrated that the shares have fallen despite the expansion news, while others blame sector weakness and short-selling pressure.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

CMG is drawing attention amid a sharp selloff, with traders pointing to broader restaurant-sector weakness, cautious consumer spending, and concerns about Chipotles prices, portions, and traffic. Some are also speculating about a possible takeover bid, but the buyout claims remain unconfirmed and opinions are divided between dip-buying and further downside.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 open-label extension data for deramiocel in Duchenne muscular dystrophy is driving attention, with traders highlighting slower upper-limb decline after placebo patients switched to treatment and the datas inclusion in the amended BLA ahead of the November 22 FDA decision. Reactions are split between optimism that the results strengthen the approval case and concern that open-label findings may not resolve the FDAs prior efficacy and analysis questions; some also question the muted, volatile share-price response.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is drawing attention after a sizable order for electronic safe-and-arm devices tied to a European munitions program, alongside Citizens initiating coverage with an Outperform rating. Bulls view the contract as validation of its recent acquisitions and a potential catalyst, while skeptics argue one order does not resolve execution, dilution, and heavy short-interest concerns.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

OpenAI CEO Sam Altmans statement that Cerebras remains a close partner has eased concern after a report said OpenAI used Nvidia GPUs for its latest Ultrafast mode, prompting a rebound in CBRS shares. Traders are debating whether the reassurance confirms Cerebras role in future workloads, while continued insider share unlocks and selling remain a bearish overhang.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs volatile moves and repeated underperformance versus Bitcoin dominate discussion, with traders debating why shares have not tracked BTCs strength. A recent rebound has sparked short-squeeze speculation, while some investors point to a possible AI data-center tenant announcement as a hoped-for catalyst; that deal remains speculation in the conversation.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs sharp rally is being linked to a cluster of launch milestones and the start of its Google AI-computing agreement, with traders also citing a technical breakout and possible short-covering. Bulls see momentum in its launch and AI businesses, while skeptics point to valuation and upcoming share unlocks as risks.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

A reported federal loan package to fund upgrades at Vistras nuclear plants is driving attention, with traders tying the plan to rising electricity demand from AI data centers. Many see it as bullish, but others are frustrated by the stocks volatile price action and note that the financing is still a reported plan rather than a completed deal.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3Ds sudden CFO departure after a short tenure is driving concern, with traders questioning the lack of detail while others view the experienced interim replacement as reassuring. Newly approved change-in-control protections have also prompted acquisition speculation, though traders note they do not confirm a deal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX I&#39;m having some fun and can hear already. People want a buyout, No Way PSS sells cheap. How about Japan? They like and want to expand in the Immunity field and are buying. PSS could get some $$ and establish a 100 Billion market cap and screw the Shorts at the same time. Japan buys a 10% percent stake  through a tender of 10 Billion dollars  , with an  exdate of May 8th. PSS sell 19% of his shares and retail sells 10% of its holdings...No Dilution!  If you owned 1,000 shares you will now have 900 shares, But will recieve approximately $10,000 as a sweetner Japan gets a 1 time option to buy 1 million doses of Anktiva at $10,000 per dose.
That would be a 10 Billion dollar sale.
Shorty must deliver it&#39;s shares by May 8th.  This could be epic and the entire world would know all about IBRX.
JUST A FUN THOUGHT! TIME FOR A BOURBON!! Some day something crazy can happen!
I can hear &quot;what have I been smoking!&quot;

FishOn

Petey99

Toby J

mr mulally

Scott Erickson

BeautifulBiosInGreen

J OByrne

John Mack

Dr. O

Pablo Neruda

thebiglong7

Johann

E.B. Matlack

harry

Kenneth Orthner

Terry Manziano

Sidney Price

Ulaughing

Rickerthestockpicker

Dan Storey

John Morin

Rob Mazzetti

h888l

$IBRX  My idea below, works in many different ways. I&#39;m  sure the Saudis or Japan would want to own some IBRX, most of us here think it will be huge in the near future!

The Doctor would sell 10% (typo) NOT  19.

StockTwits For Android 

Nick

ImmunityBio Inc

 I'm having some fun and can hear already. People want a buyout, No Way PSS sells cheap. How about Japan? They like and want to expand in the Immunity field and are buying. PSS could get some $$ and establish a 100 Billion market cap and screw the Shorts at the same time. Japan buys a 10% percent stake  through a tender of 10 Billion dollars  , with an  exdate of May 8th. PSS sell 19% of his shares and retail sells 10% of its holdings...No Dilution!  If you owned 1,000 shares you will now have 900 shares, But will recieve approximately $10,000 as a sweetner Japan gets a 1 time option to buy 1 million doses of Anktiva at $10,000 per dose.
That would be a 10 Billion dollar sale.
Shorty must deliver it's shares by May 8th.  This could be epic and the entire world would know all about IBRX.
JUST A FUN THOUGHT! TIME FOR A BOURBON!! Some day something crazy can happen!
I can hear "what have I been smoking!"

@BullriderNkg He knows how bad it is. I would NOT TRUST this with anyone but PSS.

StockTwits Web

 He knows how bad it is. I would NOT TRUST this with anyone but PSS.

JudyKay

@BullriderNkg Plenty of opportunities ahead for investors and/or partners in IBRX. Expect much BP interest in a BO but few seriously would see the benefit.
Amazon, Tesla, Netflix, etc, would all feel the same....Why?

 Plenty of opportunities ahead for investors and/or partners in IBRX. Expect much BP interest in a BO but few seriously would see the benefit.
Amazon, Tesla, Netflix, etc, would all feel the same....Why?

BIG TYPO...PSS only sells 10% of his shares NOT 19%!

@BullriderNkg I don’t think this is ever sold. Becomes a foundation

Jack

KnysnaNow

StockTwits for iOS

 I don’t think this is ever sold. Becomes a foundation